Searched for
PULMONARY FIBROSIS TREATMENT
Director of Amitabh Bachchan's superhit film 'Don' passes away. Who was Chandra Barot?Chandra Barot, the director of the iconic Bollywood film 'Don,' has passed away at 86 after battling pulmonary fibrosis. His journey to fil...- Verona Pharma stock jumps 20% on $10B Merck deal—can FDA-approved Ohtuvayre reshape COPD care?Verona Pharma stock jumped 20% after Merck announced it will acquire the British biotech in a $10 billion deal. Merck will pay $107 per sha...
- Zakir Hussain passes away after battling idiopathic pulmonary fibrosis; All you need to know about the deadly lung diseaseZakir Hussain Death Reason: Tabla maestro Zakir Hussain passed away at 73 due to idiopathic pulmonary fibrosis, a chronic lung disease. Ren...
- What is pulmonary fibrosis? Zakir Hussain had this rare lung diseaseFamous tabla virtuoso Zakir Hussain passed away at 73 in a San Francisco hospital, his family revealed on Monday. They stated that his deat...
- After two decades of the 9/11 attacks, nearly 17000 first responders are suffering from diseases like cancerIt has been way more than 20 years since the 9/11 attacks on US soil, but the effects of this brutal terror attack are still haunting the l...
- Lupin gets USFDA nod to market generic drug for treatment of lung diseaseLupin on Friday said it has received approval from US FDA to market a generic product, used in the treatment of a lung disease, in the Amer...
- Generative AI in healthcare: Seize the advantage or fall behind!The GenAI market is projected to surge to an astronomical $120 billion by 2030, with its most exciting impact anticipated in the healthcare...
- What is Influenza A H3N2 virus? 2 deaths reported in India. Symptoms, diagnosis and who are at riskSeasonal influenza is an acute respiratory infection caused by influenza viruses. The Indian Council of Medical Research (ICMR) has said th...
- Eyestem has a visionary approach to make cell therapy affordable in IndiaCell and gene therapy can go a long way in treating incurable diseases, but currently it is very pricey. Eyestem wants to dramatically cut ...
- Cipla scales up offerings, investments as it eyes global lung specialty leadershipDrugmaker Cipla said it is scaling up offerings and expanding access to medicines, inhaler devices, diagnostics, as it aspires to become th...
- Glenmark gets USFDA nod for generic lung cancer drugThe company's product is the generic version of Boehringer Ingelheim Pharmaceuticals Inc's Ofev capsules.
- COVID-19 can cause permanent damage to lungs, says studyResearch by Northwestern Memorial Hospital, Chicago, has found that Covid-19 in some patients can lead to irreversible and permanent lung d...
- Post-Covid ailments may last for life: Dr Randeep Guleria, Pulmonology specialist and AIIMS Director"Such issues get resolved in about six weeks in most cases. We advise them to exercise, have a diet with green leafy vegetables and multivi...
- Soon, norms to deal with post-recovery health issuesThe group is collecting data of cured Covid-19 patients from central government hospitals and the All India Institute of Medical Sciences i...
- Age is not the only risk for severe coronavirus diseaseThe majority of people who get COVID-19 have mild or moderate symptoms. But "majority" doesn't mean "all," and that raises an important que...
- How difficult can it be to breathe again? Dr Suryanarayan Pichai’s story of life, challenges and hope will leave you inspired
- Coping with loss: Tales of coping with familial tragedies & the quest to find new meaningEveryone has a life story to tell and collectively these stories help you accept what life is, in all its surprising twists and turns, more...
- Drug firm Venus Remedies gets nod to market generic meropenem in SwitzerlandThe company has received marketing authorisation from Swiss drug authority 'Swissmedic' through its German arm Venus Pharma GmbH for merope...
- Human stem cells converted to functional lung cells say scientistsThe advance, by Columbia University Medical Center(CUMC) researchers, has significant potential for modelling lung disease.
- Novartis to buy Nektar's pulmonary unit for $115MPharmaceutical giant Novartis AG said Tuesday it will buy the pulmonary drug unit of California-based Nektar Therapeutics for US$115 millio...
Load More
